Lv21
180 积分 2022-12-11 加入
Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial
4小时前
待确认
Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial
5小时前
求助中
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial
5小时前
已完结
665O Neoadjuvant and adjuvant pembrolizumab (Pembro) plus standard of care (SOC) for resectable locally advanced head and neck cancer (LA HNSCC) in the Asian subgroup of the phase III KEYNOTE-689 trial
5小时前
求助中
Impact of Consolidation Durvalumab on Local Control Following Chemoradiotherapy for Non–Small Cell Lung Cancer
10天前
已关闭
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial
13天前
已完结
Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial
18天前
已完结
New Strategy for Breast Cancer Related Lymphedema Treatment by Endermology: ELOCS Phase II Randomized Controlled Trial
18天前
已关闭
Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma
1个月前
已完结
Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
1个月前
已完结
皖公网安备34019202002308
